Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07158034 · ClinicalTrials.gov registry record · NA
Investigating EEG as a Biomarker for Tinnitus Improvement After Bimodal Stimulation
A NA study of Tinnitus, sponsored by University of Minnesota.
- Recruiting
- Registry status
- NA
- Development phase
- 24
- Enrollment target
- 1
- Study location
NCT07158034: Recruiting NA study of Tinnitus, sponsored by University of Minnesota.
NCT07158034 is a NA study of Tinnitus that is actively recruiting participants, run by University of Minnesota. The registered enrollment target is 24 participants, below the 12,619-participant average among 24 other Tinnitus trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07158034, a NA study of Tinnitus, is actively recruiting participants, sponsored by University of Minnesota.
- RECRUITING
- Registry status
- NA
- Development phase
- 24 participants
- Enrollment target
- 1
- Study location
Study Summary
The aim of the proposed study is to investigate the use of resting-state Electroencephalogram (EEG)-Based Brain Entropy (EBDBE) and auditory brainstem responses (ABR) as an objective measure of tinnitus improvement following the use of a bimodal stimulation device in individuals with tinnitus after six weeks of bi-modal stimulation.
Primary Outcome
Assessed via 32-channel EEG recording
Conditions Studied
Interventions
- DEVICE Lenire Device
Study Locations (1)
Minnesota
- University of Minnesota - Minneapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2025-10-03 |
| Est. Completion | 2026-06-30 |
| Phase | NA |
What NCT07158034 shows while recruiting
NCT07158034 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 24 participants, a relatively small participant target, below the 12,619-participant average among 24 other Tinnitus trials with a reported enrollment target (100% lower).
The record links to 1 condition, with Tinnitus appearing as the primary indexed condition, and to 1 intervention - of which Lenire Device is the first listed.
NCT07158034 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT07158034 about?
NCT07158034 is a clinical study titled "Investigating EEG as a Biomarker for Tinnitus Improvement After Bimodal Stimulation". The aim of the proposed study is to investigate the use of resting-state Electroencephalogram (EEG)-Based Brain Entropy (EBDBE) and auditory brainstem responses (ABR) as an objective measure of tinnitus improvement following the use of a bimodal stimulation device in individuals with tinnitus after ...
What is the current status of trial NCT07158034?
This trial is currently recruiting. It is a NA study. The enrollment target is 24 participants. The study started on 2025-10-03. Estimated completion is 2026-06-30.
What conditions does trial NCT07158034 study?
This clinical trial studies the following conditions: Tinnitus.
What interventions are being tested in trial NCT07158034?
The interventions under investigation include: Lenire Device (DEVICE).
Who is sponsoring clinical trial NCT07158034?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07158034 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Tinnitus
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07158034's enrollment target sits among peer trials
24 22nd of 24 higher than 3 of 24 other Tinnitus trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Tinnitus trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Treatment for PTSD and Tinnitus
RECRUITING · NA
-
Somatosensory Tinnitus RCT
RECRUITING · NA
-
Noninvasive Therapy for Tinnitus
RECRUITING · NA
-
External Therapy for Tinnitus Management
RECRUITING · NA
-
Mindfulness Application Effects on Mental Health Symptoms in Children With Severe Tinnitus and Misophonia
RECRUITING · NA
-
Notched Noise Therapy for Suppression of Tinnitus
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02331979 · 24 participants · NA
Improving Bladder Function in SCI by Neuromodulation
- NCT03096197 · 24 participants · NA
Exoskeleton and Spinal Cord Stimulation for SCI
- NCT03223922 · 24 participants · NA
Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases
- NCT03326921 · 24 participants · Phase 1
HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI